(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The "Malaria Diagnostics Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets's offering.
The Global Malaria Diagnostics Market is expected to grow from USD 710.504 million in 2025 to USD 908.749 million in 2030, at a CAGR of 5.05%.
The malaria diagnostics market is experiencing growth driven by the critical need for early and accurate diagnosis to manage a disease that causes significant morbidity and mortality if untreated. High-quality diagnostic kits, including molecular diagnostics and rapid diagnostic tests (RDTs), are essential for effective disease management. The market is supported by technological advancements and increased government funding, though low awareness in some regions poses challenges. This summary focuses on current trends, drivers, restraints, and key players, excluding developments prior to 2023. ![]()
Market Drivers
The primary driver of the malaria diagnostics market is the advancement in diagnostic technologies, particularly RDTs and molecular diagnostics, which enable rapid and precise detection of malaria. These innovations improve patient outcomes by facilitating timely treatment, especially in high-burden regions. Increased government funding for malaria research and awareness campaigns in developing countries is another key growth factor. These initiatives aim to enhance access to diagnostics and educate communities about the importance of early detection, particularly in endemic areas. The global burden of malaria continues to underscore the need for efficient diagnostic tools, further propelling market demand.
Market Restraints
Despite its growth potential, the malaria diagnostics market faces challenges due to low awareness among populations in certain regions, particularly in developing countries where malaria is prevalent. Limited understanding of diagnostic tools and their benefits can delay adoption and hinder effective disease management. Additionally, logistical challenges, such as inadequate healthcare infrastructure in remote areas, may restrict access to advanced diagnostics, limiting market expansion. Addressing these barriers through education and improved distribution networks is essential for sustained growth.
Market Segmentation
By Diagnostic Type
The market is segmented into molecular diagnostics and RDTs, with RDTs dominating due to their ease of use, affordability, and suitability for point-of-care testing in resource-limited settings. Molecular diagnostics, while more precise, are gaining traction in advanced healthcare systems for their ability to detect low-level infections. Both segments are critical to addressing diverse diagnostic needs across global markets.
By Geography
The malaria diagnostics market is concentrated in high-burden regions, particularly Sub-Saharan Africa and parts of Asia, where malaria prevalence drives demand. Africa remains the largest market due to its significant disease burden and increasing government-led initiatives. The Asia-Pacific region is also growing, supported by rising investments in healthcare infrastructure and awareness programs. Developed regions like North America and Europe contribute through research and development of advanced diagnostic technologies.
Key Industry Players
Major players in the malaria diagnostics market include Motic (Xiamen) Electric Group Co., Ltd., Sight Diagnostics Ltd., bioMerieux SA, Intellectual Ventures Laboratory, LLC, Access Bio, Inc., Sysmex Europe GmbH, Abbott Laboratories, Meridian Bioscience, Inc., QuantuMDx Group Ltd., Hemex Health, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., and Premier Medical Corporation Pvt. Ltd. These companies are driving innovation in diagnostic technologies and expanding access to testing solutions.
The malaria diagnostics market is poised for growth, driven by technological advancements and increased funding for malaria control. Low awareness and logistical challenges remain hurdles, particularly in endemic regions. With a focus on RDTs and molecular diagnostics, and strong growth in Africa and Asia-Pacific, the market is well-positioned to address global malaria challenges, provided stakeholders prioritize education and accessibility.
Key Benefits of this Report:
Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments. Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy. Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments. Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment. Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence.
Report Coverage:
Historical data from 2020 to 2024 & forecast data from 2025 to 2030 Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis Competitive Positioning, Strategies, and Market Share Analysis Revenue Growth and Forecast Assessment of segments and regions including countries Company Profiling: Strategies, Products, Financial Information, and Key Developments among others.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 142 |
| Forecast Period | 2025-2030 |
| Estimated Market Value (USD) in 2025 | $710.5 Million |
| Forecasted Market Value (USD) by 2030 | $908.75 Million |
| Compound Annual Growth Rate | 5% |
| Regions Covered | Global |
Key Topics Covered
1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. MALARIA DIAGNOSTICS MARKET BY TECHNOLOGY
5.1. Introduction
5.2. Rapid Diagnostic Tests (RDTs)
5.3. Microscopy
5.4. Molecular Diagnostics
5.5. Serology-based Tests
5.6. Other Technologies
6. MALARIA DIAGNOSTICS MARKET BY END-USERS
6.1. Introduction
6.2. Hospitals and Clinics
6.3. Diagnostic Laboratories
6.4. Research Institutes
6.5. NGOs and Government Health Programs
7. MALARIA DIAGNOSTICS MARKET BY DISTRIBUTION CHANNEL
7.1. Introduction
7.2. Direct Tenders & Institutional Sales
7.3. Retail and Private
8. MALARIA DIAGNOSTICS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Technology
8.2.2. By End-Users
8.2.3. By Distribution Channel
8.2.4. By Country
8.2.4.1. USA
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Technology
8.3.2. By End-Users
8.3.3. By Distribution Channel
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Technology
8.4.2. By End-Users
8.4.3. By Distribution Channel
8.4.4. By Country
8.4.4.1. United Kingdom
8.4.4.2. Germany
8.4.4.3. France
8.4.4.4. Spain
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Technology
8.5.2. By End-Users
8.5.3. By Distribution Channel
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. UAE
8.5.4.3. Others
8.6. Asia Pacific
8.6.1. By Technology
8.6.2. By End-Users
8.6.3. By Distribution Channel
8.6.4. By Country
8.6.4.1. China
8.6.4.2. Japan
8.6.4.3. South Korea
8.6.4.4. India
8.6.4.5. Indonesia
8.6.4.6. Thailand
8.6.4.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Motic (Xiamen) Electric Group Co., Ltd.
10.2. Sight Diagnostics Ltd.
10.3. bioMerieux SA
10.4. Intellectual Ventures Laboratory, LLC
10.5. Access Bio. Inc.
10.6. Sysmex Europe GmbH
10.7. Abbott Laboratories
10.8. Meridian Bioscience, Inc.
10.9. QuantuMDx Group Ltd.
10.10. Hemex Health, Inc.
10.11. F. Hoffmann-La Roche Ltd.
10.12. Bio-Rad Laboratories, Inc.
10.13. Thermo Fisher Scientific Inc.
10.14. Premier Medical Corporation Pvt. Ltd.
For more information about this report visit
About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
Global Malaria Diagnostics Market
CONTACT:
CONTACT:
Laura Wood,Senior Press Manager
...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
![]()
MENAFN25092025004107003653ID1110111676
Comments
No comment